Rallis India Ltd Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 4- Near term growth to be volume-led due to price volatility and sharp price reductions.
- Domestic consumption expected to improve as the monsoon progresses, potentially driving volume growth.
- Export markets remain cautious due to inventory overhang and price erosions, especially for products like Acephate.
- New products and better product mix targeted to improve realizations and drive volume growth.
- Trial production at new Multi-Purpose Plant (MPP) started; commercial revenue expected from Q2, with around 60% capacity utilization in the first year.
- Innovation Turnover Index (new products contribution) aims to increase, supporting sustainable growth.
- Overall revenue growth challenged by global demand reduction and pricing pressures but supported by diversified portfolio across domestic/international crop protection, nutrition, and seeds.
- Focus on improving collections and managing inventory to support cash flow and EBITDA.
- Optimism on volume recovery in international markets like Brazil if upcoming seasons perform well.
See what Rallis India Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- No specific mention of any new fundraising through debt or equity in the current quarter.
- The company repaid Rs. 25 crore of working capital loan during the quarter, indicating a focus on reducing debt.
- Capex for the year is expected to be around Rs. 150 crore, to be funded presumably through internal accruals.
- Future investments include R&D and manufacturing capacity expansion, but no explicit plans for external fundraising are stated.
- Management emphasizes sustaining cash flow and EBITDA, with no indication of raising new capital via equity or debt in the near term.
See what Rallis India Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- Planned capex for the year is approximately Rs.150 crore.
- Part of the capex will go towards a new R&D facility.
- Some capex will be used for de-bottlenecking one or two products with good opportunity.
- New Multi-Purpose Plant (MPP) at Dahej SEZ started trial production in June; revenue expected from Q2 onwards.
- Expected capacity utilization of the new MPP is about 60% in the first year, improving in subsequent years.
- Capex will support seeding new opportunities, scaling new products, and expanding manufacturing capabilities.
- Focus on longer-term investment decisions evaluated via internal rate of return.
- Efforts ongoing to reduce dependency on China for raw materials through capex and portfolio diversification.
Track Rallis India Ltd — get its next earnings analysis in your feed
Margin guidance
Category 3- Near-term challenges due to sharp price reductions and global demand reduction caused by channel inventory overhang.
- Volume-led growth is expected to be the key driver; price-led revenue growth will be challenging.
- Focus on improving realizations through better product mix and dynamic pricing.
- Diverse portfolio across domestic/international markets, crop nutrition, and seeds business offers stability.
- Investments in R&D, product development, and manufacturing to support sustainable growth.
- Margin improvement dependent on multiple factors, including seasonality and domestic business performance.
- Innovation Turnover Index targeted at ~15% to support new product scaling.
- New manufacturing facility (MPP) expected to achieve ~60% utilization in the first year, with improvement next year.
- Overall, earnings growth is cautiously optimistic, hinging on volume recovery, product launches, and improved pricing realizations.
Order book
How does Rallis India Ltd rank vs peers in Fertilizers & Agrochemicals?
Pro featureHow does Rallis India Ltd rank in Fertilizers & Agrochemicals?
Compare Rallis India Ltd against every Fertilizers & Agrochemicals company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Rallis India Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- GSP Crop Science (Q1 FY27)
Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…
- Sharda Cropchem (Q4 FY25)
Globally, the company’s current 4%-5% global market share offers scope to increase, meaning a 1% global share gain equates to 20%-25% volume growth for them…
- Sumitomo Chemi. (Q2 FY26)
Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…
- Indogulf Cropsci (Q3 FY26)
The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…